Cite
HARVARD Citation
Lee, E. et al. (n.d.). THU0140 Tofacitinib (CP-690, 550), an oral janus kinase inhibitor: Analysis of gastrointestinal adverse events across the rheumatoid arthritis clinical programme. Annals of the rheumatic diseases. pp. 202-203. [Online].